Sep 6, 2022 | Main Page Post, Rejuvenair
Metered Cryospray treats damaged airways enabling a rejuvenative healing response BOSTON, Sept. 6, 2022 /PRNewswire/ — CSA Medical, Inc., today announced results from the first randomized, controlled study of Metered Cryospray (MCS) utilizing the RejuvenAir®...
May 13, 2021 | Main Page Post, Product News, Rejuvenair, SPRAY-CB
These results should provide the scientific proof behind the remodeling response and clinical improvements identified in earlier studies Boston, MA—May 12, 2021: CSA Medical, Inc., today announced ® that all subjects have been enrolled in the RejuvenAir System study...
Apr 19, 2021 | Main Page Post, Product News, Rejuvenair, SPRAY-CB
Boston, MA –April 19, 2021: CSA Medical, Inc., today announced that Wissam Abouzgheib, MD, chief of pulmonary medicine at Cooper University Health Care, Camden, New Jersey, has joined the SPRAY-CB Study investigating a new device treatment for COPD with Chronic...
Nov 23, 2020 | Main Page Post, Product News, Rejuvenair
The RejuvenAir System is designed to address the underlying cause of COPD with Chronic Bronchitis and enable rejuvenative healing of the airways BOSTON, Nov. 23, 2020 — CSA Medical, Inc., today announced metered cryospray utilizing the RejuvenAir® System for the...
Nov 11, 2020 | Main Page Post, Product News, Rejuvenair
This study will provide a scientific rationale for the remodeling response and clinical improvements identified in the feasibility study Boston, MA –November 11, 2020: CSA Medical, Inc., today announced that over half of the subjects in a 32 patient study,...
